Clarivate
NYSE:CCCClarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
SOPHiA GENETICS
NASDAQ:SOPHSOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.
3798 (SXS.V)
CVE:SXSSolimar Energy Limited (Solimar) is an Australia-based oil and gas production and exploration company. The Company has a multi-project asset base focused in the oil prolific San Joaquin Basin, onshore California. The Company's assets are mainly in oil prone trends adjacent giant fields and target both conventional (sandstone) and unconventional (fractured oil shale) reservoirs. Solimar is engaged in conversion of an oil and gas resource potential within its acreage to reserves. The Company operates most of its assets, holding high equity positions. This includes a control position in the Kreyenhagen oil field with significant volumes of oil intersected by numerous wells within the Company's control acreage. The Company's projects include Kreyenhagen, Bayswater, Jacalitos, SELH, Paloma and Tejon Footwall. The Company's subsidiaries include Solimar Australia Energy Pty Ltd and Livingstone Energy Inc.